/ Updated on

Biomark to Expand Treatment Response Trial to Advanced Lung Cancer Patients Receiving Immunotherapy

BioMark Diagnostics Inc. is pleased to announce that Health Canada has approved its clinical trial application (CTA).

See the original article : here

Our events Media center About us Contact information
Choose the Québec City region
Our economic statistics Our business environment Our industries Francophonie
Québec International
Our team Our careers Our partners Our Board of directors Our privacy policy
Business services
Recrutement international Sales and export Technological entrepreneurship R&D and innovation Set up and business expansion Industrial networking
International talent
Visit Québec First
1035 Avenue Wilfrid-Pelletier bureau 400, Québec QC G1W 0C5
© 2024 Québec International
Gouvernement du Québec Government of Canada Ville de Québec